SEINE BIO · SCIENCE LIBRARY
Sermorelin
Sermorelin is a GHRH(1–29) analogue with a history in pediatric growth-hormone deficiency assessment and treatment.
Research compoundA closer look at the research, the uncertainties and the questions worth asking.
THE FULL READING GUIDE · UPDATED OCTOBER 7, 2026
Inside the science of Sermorelin.
Educational purpose only. Not medical advice. Consult licensed provider. Obtain from authorized compounding pharmacies only.
Compounding is an option only where the particular substance, product, and prescribing pathway are lawful; a pharmacy cannot make every research compound available for patient use. Approved finished medicines may also be obtained from licensed non-compounding pharmacies.
Overview
Sermorelin is a growth hormone-releasing hormone fragment studied for stimulating pituitary growth-hormone secretion. Its regulatory history is more specific than a broad “anti-aging peptide” description. Historical pediatric growth-failure treatment and diagnostic uses must be distinguished from today’s adult wellness marketing.
Community Use
Peptidepedia discusses sermorelin in performance and hormone-release terms. PeptideDosages.com publishes informal protocols. These pages reflect community interest, not a current FDA adult anti-aging label. A hormone-response claim is narrower than a demonstrated improvement in energy, physique, or quality of life.
Doses, Durations & Cycles
Informal biohacking protocols and published regimens. Attributed website reports for education, not medical recommendations. Multiple publications document circulation; they do not establish a safe dose or validate a cycle.
| Route / formulation | Dose / reported phases | Frequency | Duration / break | Notes and source |
|---|---|---|---|---|
| Subcutaneous | 200–300 mcg initially; the page describes 400–500 mcg after 4–8 weeks. | At bedtime, five nights weekly. | 3–6 months before reassessment. Break: Two nights each week; some described schedules add 1–3 months between courses. | Published informal biohacking claim TrimRX |
| Subcutaneous | 200 mcg in weeks 1–2, 300 mcg in weeks 3–4, 400 mcg in weeks 5–6, and 500 mcg in weeks 7–8. | The detailed schedule says once nightly; quickstart instead says five nights weekly. | The protocol section says 8–12 weeks, with optional extension to 16 weeks. Break: Quickstart specifies four weeks between courses, plus two off nights weekly. | Published informal biohacking claim ALTRD Protocol |
Important context: ALTRD has conflicting frequency and duration summaries. A single starting/average/maximum table is not supported by agreement between these pages.
Sources checked October 7, 2026. Educational listing does not establish prescribing approval or availability through Seine Bio.
An archived pediatric label is not a dosing template for an adult wellness page, so its pediatric regimen is not reproduced here. No FDA-approved adult anti-aging cycle is established. The chart preserves source context; any lawful proposed preparation requires an individual clinical plan rather than an imported community schedule.
Research Findings
The FDA Geref record lists discontinued products. A 2013 FDA determination explains the historical pediatric growth-failure indication and distinguishes withdrawal from a safety or effectiveness finding. Neither record demonstrates a benefit for healthy adults seeking anti-aging treatment. The FDA secretagogue briefing provides additional adult-growth-hormone context.
U.S. Approval & Access
Sermorelin’s historical approval does not establish a currently approved adult anti-aging program. Any compounded product must have a lawful substance and pharmacy pathway and is not itself FDA-approved. “Not withdrawn for safety or effectiveness” is a historical regulatory finding, not authorization for every current wellness claim.
What It Does in the Body
Sermorelin acts on a growth hormone-releasing hormone pathway, requiring an appropriate pituitary response. That differs from direct growth-hormone replacement and does not address every cause of fatigue or changing body composition. A biochemical response should be interpreted in the clinical context rather than described as a universal hormone optimization benefit. For the uses discussed here, reliable clinical onset, peak benefit, and duration are not established. Route-specific human peak exposure and persistence cannot be inferred from community schedules or a laboratory response.
Benefits & Reported Experiences
The historical records do not establish a dependable adult wellness result timeline or success rate. Ask what actual adult outcome was studied, how the condition was defined, and whether the exact product was used. A rise in a hormone marker cannot substitute for meaningful improvement in function or symptoms.
Side Effects & Risks
Historical use cannot establish the adverse-event rate of every modern formulation or prolonged wellness schedule. Review relevant medical history, metabolic conditions, and concurrent hormone treatments with the clinician. “Stimulating natural release” is a description of a pathway, not an assurance that treatment is appropriate for every adult.
Delivery Options
Historical diagnostic and therapeutic products may have different formulations and contexts. A present-day preparation needs its own route-specific instructions and quality assessment. This profile does not supply administration technique, mixing directions, or dose conversions and does not recommend powders for self-reconstitution.
Product Quality & Storage
Confirm whether the proposal is an approved finished product, a lawful compounded preparation, or an investigational product. Those categories have different evidence and oversight. The Geref history does not prove that a current supplier’s preparation matches the studied product or that an adult marketing claim is supported. Storage must follow the authorized finished product’s labeling or an approved study protocol; temperatures and beyond-use times cannot be inferred from research-vial guidance.
Combinations & Interactions
Pairing sermorelin with another secretagogue is discussed online, but a stronger hormonal response does not establish better patient outcomes. The historical Geref records do not validate a modern anti-aging combination. Ask for evidence about the exact combination and condition; no consumer stack is supplied here.
Talking With Your Provider
For hormone concerns, fatigue, or body-composition changes, begin with a clinical assessment and discuss established options. Ask why a proposed treatment fits the diagnosis, what monitoring is needed, and what evidence supports its expected benefit. Membership does not guarantee a specific hormone product or prescription.
Educational purpose only. Not medical advice. Consult licensed provider. Obtain from authorized compounding pharmacies only.
Compounding is an option only where the particular substance, product, and prescribing pathway are lawful; a pharmacy cannot make every research compound available for patient use. Approved finished medicines may also be obtained from licensed non-compounding pharmacies.
Questions about what you read?
Explore the research library Create a free account
Educational information only. A free account lets you request review of your care goals. This profile does not establish availability, clinical suitability or access to the named compound.
Explore clinically appropriate options with a licensed provider. Inquiry does not guarantee a prescription, research-program acceptance or access to a particular substance.
Questions worth bringing to your appointment.
- Are there alternatives that address my goal?
- If treatment is appropriate, what monitoring and follow-up would I need?
- Could my health history or current medicines change the risks?
Saved discussion topics 0
Save topics you would like to discuss with your healthcare provider. Saving is an expression of interest, not a treatment request or medical recommendation.
Saved only in this browser, on this device—not in a patient account. Other people using this browser may see your list. Clear it when using a shared device. This list is not sent to our team.
Explore your next step with SEINE BIO.
Bring your questions to a wellness consultation. Inclusion in this library does not indicate prescribing or product availability. A consultation does not guarantee a prescription.
Explore consultations Back to Growth-hormone signalingEducational information · U.S. context · October 7, 2026. No ordering, personalized dosing or injection instructions.
Bring your saved topics to your care team.
Members can select up to five favorites and send a message for review. Your saved list stays in this browser until you choose what to submit.
Choose saved topics for review →